fluconazole has been researched along with Drug Abuse, Intravenous in 15 studies
Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.
| Excerpt | Relevance | Reference |
|---|---|---|
| "An addicted, intravenous drug user was treated for Candida albicans tricuspid valve endocarditis with high dose fluconazole for 8 months, without relapse after 30 months." | 7.73 | Candida albicans tricuspid valve endocarditis in an intravenous drug addict: successful treatment with fluconazole. ( Julander, I; Thalme, A; Westling, K, 2005) |
| " We report an informative case of endogenous endophthalmitis related to injection of cocaine mixed with lemon juice." | 3.74 | Endophthalmitis associated with intravenous drug use. ( Keyashian, K; Malani, PN, 2007) |
| "An addicted, intravenous drug user was treated for Candida albicans tricuspid valve endocarditis with high dose fluconazole for 8 months, without relapse after 30 months." | 3.73 | Candida albicans tricuspid valve endocarditis in an intravenous drug addict: successful treatment with fluconazole. ( Julander, I; Thalme, A; Westling, K, 2005) |
| "Fluconazole compliance was monitored electronically by using the Medication Event Monitoring Systems with 19 women receiving fluconazole at 50 mg thrice weekly for prophylaxis of recurrent mucocutaneous candidiasis." | 2.68 | Electronic compliance assessment of antifungal prophylaxis for human immunodeficiency virus-infected women. ( Bettencourt, FA; Dudley, MN; Fiore, TC; Flanigan, TP; Geletko, SM; Mayer, KH; Segarra, M, 1996) |
| "Endogenous fungal endophthalmitis is mostly seen as opportunistic infection, particularly in immunocompromised patients and under special risk factors." | 1.31 | [Candida endophthalmitis in drug abuse. case report. ( Faulborn, J; Haller-Schober, EM; Klein, A, 2000) |
| "Fluconazole has shown effectiveness in maintenance therapy, being not be possible to evaluate it as an acute phase therapy because the low number of cases in which it was studied." | 1.28 | [Cryptococcosis in AIDS patients: a study of 19 cases]. ( Adrados de Llano, M; García Aguado, C; Gazapo Carretero, E; González Lahoz, JM; Martínez Blanco, ML; Verdejo Ortes, J, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (33.33) | 18.2507 |
| 2000's | 7 (46.67) | 29.6817 |
| 2010's | 3 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fennelly, AM | 1 |
| Slenker, AK | 1 |
| Murphy, LC | 1 |
| Moussouttas, M | 1 |
| DeSimone, JA | 1 |
| Lo, JS | 1 |
| Lo, JO | 1 |
| Hunter, AJ | 1 |
| Vervaeke, S | 1 |
| Vandamme, K | 1 |
| Boone, E | 1 |
| De Laere, E | 1 |
| Swinne, D | 1 |
| Surmont, I | 1 |
| Wu, CJ | 1 |
| Lee, HC | 1 |
| Yang, YL | 1 |
| Chang, CM | 1 |
| Chen, HT | 1 |
| Lin, CC | 1 |
| Lee, NY | 1 |
| Chu, WL | 1 |
| Hsieh, LY | 1 |
| Wang, YL | 1 |
| Lauderale, TL | 1 |
| Tseng, FC | 1 |
| Ko, NY | 1 |
| Ko, WC | 1 |
| Lo, HJ | 1 |
| Lefort, A | 1 |
| Chartier, L | 1 |
| Sendid, B | 1 |
| Wolff, M | 1 |
| Mainardi, JL | 1 |
| Podglajen, I | 1 |
| Desnos-Ollivier, M | 1 |
| Fontanet, A | 1 |
| Bretagne, S | 1 |
| Lortholary, O | 1 |
| Westling, K | 1 |
| Thalme, A | 1 |
| Julander, I | 1 |
| Horcajada, JP | 1 |
| Fernández-Sampedro, M | 1 |
| García-Palomo, D | 1 |
| Cañal, J | 1 |
| Salesa, R | 1 |
| Farinas, MC | 1 |
| Jeragh, A | 1 |
| Ahmad, S | 1 |
| Naseem, J | 1 |
| Khan, ZU | 1 |
| Keyashian, K | 1 |
| Malani, PN | 1 |
| Laguna, F | 1 |
| Rodríguez-Tudela, JL | 1 |
| Enríquez, A | 1 |
| Chavanet, P | 1 |
| Lopez, J | 1 |
| Grappin, M | 1 |
| Bonnin, A | 1 |
| Duong, M | 1 |
| Waldner, A | 1 |
| Buisson, M | 1 |
| Camerlynck, P | 1 |
| Portier, H | 1 |
| Geletko, SM | 1 |
| Segarra, M | 1 |
| Mayer, KH | 1 |
| Fiore, TC | 1 |
| Bettencourt, FA | 1 |
| Flanigan, TP | 1 |
| Dudley, MN | 1 |
| Gatti, M | 1 |
| Di Silverio, A | 1 |
| Cespa, M | 1 |
| Mosca, M | 1 |
| Klein, A | 1 |
| Haller-Schober, EM | 1 |
| Faulborn, J | 1 |
| Gazapo Carretero, E | 1 |
| García Aguado, C | 1 |
| Adrados de Llano, M | 1 |
| Martínez Blanco, ML | 1 |
| Verdejo Ortes, J | 1 |
| González Lahoz, JM | 1 |
1 review available for fluconazole and Drug Abuse, Intravenous
| Article | Year |
|---|---|
Candida cerebral abscesses: a case report and review of the literature.
Topics: Administration, Intravenous; Administration, Oral; Adolescent; Adult; Amphotericin B; Brain Abscess; | 2013 |
1 trial available for fluconazole and Drug Abuse, Intravenous
| Article | Year |
|---|---|
Electronic compliance assessment of antifungal prophylaxis for human immunodeficiency virus-infected women.
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis, Chronic Mucocutaneous; | 1996 |
13 other studies available for fluconazole and Drug Abuse, Intravenous
| Article | Year |
|---|---|
"String-of-pearls".
Topics: Adult; Antifungal Agents; Candidiasis; Endophthalmitis; Fluconazole; Humans; Substance Abuse, Intrav | 2008 |
A case of Candida lambica fungemia misidentified as Candida krusei in an intravenous drug abuser.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Diagnostic Errors; Drug Resistance, Fungal; | 2008 |
Oropharyngeal yeast colonization in HIV-infected outpatients in southern Taiwan: CD4 count, efavirenz therapy and intravenous drug use matter.
Topics: Adult; AIDS-Related Opportunistic Infections; Alkynes; Anti-HIV Agents; Antifungal Agents; Benzoxazi | 2012 |
Diagnosis, management and outcome of Candida endocarditis.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antibodies, Fungal; Antifungal Agents; Anti | 2012 |
Candida albicans tricuspid valve endocarditis in an intravenous drug addict: successful treatment with fluconazole.
Topics: Antifungal Agents; Candidiasis; Endocarditis; Female; Fluconazole; Heart Valve Diseases; Humans; Mid | 2005 |
Endogenous ocular candidiasis: changes in epidemiology and factors associated with poor functional outcome.
Topics: Adult; Amphotericin B; Antifungal Agents; Candidiasis; Eye Infections, Fungal; Female; Fluconazole; | 2007 |
Candida lusitaniae arthritis in an intravenous drug user.
Topics: Adult; Amphotericin B; Arthritis, Infectious; Blood Sedimentation; Candida; Candidiasis; Fluconazole | 2007 |
Endophthalmitis associated with intravenous drug use.
Topics: Antifungal Agents; Beverages; Candidiasis; Citrus; Cocaine; Cocaine-Related Disorders; Endophthalmit | 2007 |
Fungemia due to fluconazole-resistant Candida albicans in a patient with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; Candida albicans; Candidiasis; Drug | 1994 |
Cross-sectional study of the susceptibility of Candida isolates to antifungal drugs and in vitro-in vivo correlation in HIV-infected patients.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candida; Candidiasis, Oral; Cross-Sectiona | 1994 |
Primary unusual cutaneous cryptococcosis in an HIV former drug-abuser patient.
Topics: Adult; AIDS-Related Opportunistic Infections; Animals; Antifungal Agents; Columbidae; Cryptococcosis | 1997 |
[Candida endophthalmitis in drug abuse. case report.
Topics: Adult; Antifungal Agents; Candidiasis; Endophthalmitis; Fluconazole; Heroin Dependence; Humans; Male | 2000 |
[Cryptococcosis in AIDS patients: a study of 19 cases].
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Cryptococcosis; Cryptococcus neoformans; | 1992 |